PATENT CLAIM ANALYSIS

Application Number: 16267454
Application Type: Utility
Filing Date: 2019-02
Publication Date: 2019-05
Patent Classification: ["424", "227100"]

Abstract:
Provided herein are nucleic acid sequences that encode novel consensus amino acid sequences of HBV core protein, as well as genetic constructs/vectors and vaccines that express said protein sequences. Also provided herein are methods for generating an immune response against HBV using the nucleic acid sequences that are provided.

Claim (Index 8):
The nucleic acid molecule of  claim 1  wherein the nucleic acid molecule is an expression vector and sequences encoding said one more proteins are operable linked to regulatory elements.

Metadata:
- Claim Count in Document: 41.0
- Percentile: 99.0
- Lexical Diversity: 1.44444
- Patent Class: 424.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15213747', '13984771', '14978329', '13622965', '14552030']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7922280403901238
- 35 USC 102 Novelty (BERT): 0.5959304270025817
- Combined Prediction Score: 0.7725982790513697
- Mean Citation Score: 485.475836
- Max Citation Score: 529.6081
- Similarity Product: 433.7224574299932

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test